NCT05689463

Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: University Hospital, Rouen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to evaluate the prevalence of positive anti BP180 and/or anti BP230 serology in the serum of patients with chronic and diffuse pruritus for at least 1 month under immunotherapy and in the absence of obvious pruritic dermatosis (e.g. scabies, contact eczema...).

Conditions

• Patients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy

Interventions

Type	Name	Description
BIOLOGICAL	characterisation of immunoglobulin subclasses	For patients with positive anti BP180 and/or anti BP230 serology, a characterisation of the immunoglobulin subclasses will be performed

Timeline

• Start date: 2023-02-23
• Primary completion: 2027-02-01
• Completion: 2027-02-01
• First posted: 2023-01-19
• Last updated: 2026-02-06

Locations

1 site across 1 country: France